Saturday 17 October 2026 Export BGLC’s income statement to Excel — free account

BioNexus Gene Lab Corp.

BGLC Basic Materials Specialty Chemicals

BioNexus Gene Lab Corp.’s revenue for fiscal 2025 (year ended December 2025) was $7.4 million, down 21.9% from fiscal 2024. In the quarter to June 2026, revenue fell 96.6%, EPS grew 64.7% and free cash flow grew 44.3%, each against the same quarter a year earlier.

1.20 0.02 −1.64%

Follow BGLC

Alert me

Market cap: $3.6M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: 4/9
Altman Z: 6.34
Beneish M: −3.31
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	5	5	3	3
ROE Full definition →		(28.35%)	(35.24%)	(36.62%)	(33.66%)
ROA Full definition →		(24.68%)	(30.32%)	(31.37%)	(28.38%)
ROIC Full definition →		(37.43%)	(40.50%)	(43.22%)	(37.16%)
Return on Tangible Assets Full definition →		(35.23%)	(45.73%)	(48.60%)	(45.43%)
Average Days of Receivables Full definition →		66.51	31.90	15.84	21.68
Free Cash Flow per Share Full definition →		(1.46)	(1.01)	(0.49)	(0.35)
Free Cash Flow Full definition →		(2.62)	(1.88)	(1.19)	(0.85)
Capital Expenditures Full definition →		(0.04)	(0.04)	(0.03)	(0.01)
Other line items
Cash ROIC Full definition →		(26.98%)	(14.82%)	(9.83%)	(7.52%)
Accounts Receivable Turnover Full definition →		5.85	6.42	5.32	2.73
Accounts Payable Turnover Full definition →		0.00	12.25	6.07	4.60
Inventory Turnover Full definition →		6.73	6.14	4.95	2.93
Average Days of Payables Full definition →		0.00	0.13	0.17	1.05
Days of Inventory on Hand Full definition →		45.58	38.96	53.29	86.95
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.60%	0.68%	1.00%	1.73%
Selling, General and Administrative Expense of Revenue Full definition →		40.75%	54.77%	66.18%	87.11%
Share Based Compensation of Revenue Full definition →		0.00%	13.29%	0.00%	0.00%
Operating CF/Net income Full definition →		1.12	0.62	0.40	0.33
Depreciation/Fixed assets Full definition →		0.11	0.11	0.11	0.11
Capex/Depreciation Full definition →		(0.24)	(0.22)	(0.16)	(0.04)
Revenue per Share Full definition →		5.27	4.00	2.20	1.29
Operating CF per Share Full definition →		(1.44)	(0.99)	(0.48)	(0.35)
Capex per Share Full definition →		(0.02)	(0.02)	(0.01)	0.00
Capex to Sales Full definition →		0.00	0.01	0.01	0.00

Show all line items

Columns are period end dates

Stockrow Weekly